Ken Griffin Prime Medicine, Inc. Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 74,000 shares of PRME stock, worth $301,920. This represents 0.0% of its overall portfolio holdings.

Number of Shares
74,000
Previous 57,700 28.25%
Holding current value
$301,920
Previous $403,000 5.71%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$4.3 - $8.03 $410,529 - $766,640
-95,472 Reduced 88.24%
12,726 $65,000
Q1 2024

May 15, 2024
BUY
$6.35 - $9.39 $687,057 - $1.02 Million
108,198 New
108,198 $757,000
Q3 2023

Nov 14, 2023
BUY
$9.5 - $15.07 $61,978 - $98,316
6,524 New
6,524 $62,000

Others Institutions Holding PRME

# of Institutions
126
Shares Held
64.7M
Call Options Held
127K
Put Options Held
51.3K
View Full List

About Prime Medicine, Inc.

PRME Quotes by TradingView
  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $391M
More about PRME
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email